Skip to main content
Fig. 6 | Molecular Neurodegeneration

Fig. 6

From: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology

Fig. 6

Reduced microglial and astrocytic response to tau induced by ApoeCh. a, c Representative confocal images of immunostained dentate gyrus for GFAP (blue, a) and IBA1 (red, c) of 9-mo-old WT, ApoeCh, PS19, and PS19;ApoeCh mice. Scale bar = 100 µm. b,d Quantification of total volume of GFAP+ cells (b) and IBA1+ cells (d), n = 4–6 mice/sex/genotype. Sex of individual animals is denoted by pink (female) or blue (male) circles. Data are represented as mean ± SEM. Two-way ANOVA followed by Tukey’s post hoc tests to examine biologically relevant interactions. Statistical significance is denoted by *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. e Cell types plotted in XY space. f Proportion of the number of cells in each major cell type, grouped by genotype. g-k Immunofluorescence images for Human Tau, Phospho-Tau (S214), CD11c, IBA1, and GFAP in representative brains of WT, ApoeCh, PS19, and PS19;ApoeCh mice. l Aggregate expression of differentially expressed proteins (DEPs) in microglia, astrocytes, and neurons across the four genotypes. Expression is normalized for the number of brains in each genotype

Back to article page